Product Name

  • Name

    DESIPRAMINE

  • EINECS 200-040-0
  • CAS No. 50-47-5
  • Article Data27
  • CAS DataBase
  • Density 1.047 g/cm3
  • Solubility
  • Melting Point 212°C
  • Formula C18H22 N2
  • Boiling Point 407.4 °C at 760 mmHg
  • Molecular Weight 266.386
  • Flash Point 160.5 °C
  • Transport Information
  • Appearance
  • Safety 36
  • Risk Codes 20/21/22
  • Molecular Structure Molecular Structure of 50-47-5 (DESIPRAMINE)
  • Hazard Symbols HarmfulXn
  • Synonyms 5H-Dibenz[b,f]azepine,10,11-dihydro-5-[3-(methylamino)propyl]- (6CI,8CI); 10,11-Dihydro-5-[3-(methylamino)propyl]-5-H-dibenz[b,f]azepine;DMI; DMI (pharmaceutical); Demethylimipramine; Desimipramine; Desipramin;Desipramine; Desmethylimipramine; Imipramine, demethyl-;Methylaminopropyliminodibenzyl; Monodemethylimipramine; N-Desmethylimipramine;Norimipramine
  • PSA 15.27000
  • LogP 3.98870

Synthetic route

formaldehyd
50-00-0

formaldehyd

didesmethylimipramine
2095-95-6

didesmethylimipramine

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
Stage #1: formaldehyd In methanol at 20℃; for 0.25h;
Stage #2: didesmethylimipramine With methanol; sodium tetrahydroborate at 80℃; for 0.666667h; Microwave irradiation;
44%
10,11-dihydro-N-methyl-N-(methyl-d3)-5H-dibenz(b,f)azepine-5-propanamine
65100-48-3

10,11-dihydro-N-methyl-N-(methyl-d3)-5H-dibenz(b,f)azepine-5-propanamine

A

desipramine
50-47-5

desipramine

B

5-[3-(N-trideuteromethylamino)propyl]iminodibenzyl
65100-49-4

5-[3-(N-trideuteromethylamino)propyl]iminodibenzyl

Conditions
ConditionsYield
With liver microsomes of a rat Product distribution; other reagent (anodic oxidation);
impramine
50-49-7

impramine

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With D-glucose; corn steep liquor; S. aureus; peptone; yeast extract In water at 37℃; Product distribution; other reagents;
With oxygen; palladium on activated charcoal In methanol for 24h; Ambient temperature;
With pooled human liver microsomes; Tris buffer; NADPH; magnesium chloride at 37℃; pH=7.4; Enzyme kinetics;
With human hepatic CYP1A2; human hepatic CYP2C9; human hepatic CYP3A4 Enzymatic reaction;
Multi-step reaction with 2 steps
1: N,N,N',N'-tetramethyl-1,8-diaminonaphthalene / 1,2-dichloro-ethane / 1 h / Reflux
2: 2 h / Reflux
View Scheme
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

desipramine
50-47-5

desipramine

B

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

C

10-Hydroxyimipramine
796-28-1

10-Hydroxyimipramine

Conditions
ConditionsYield
In water Ambient temperature; M. griseo-cyanus (ATCC 1207a); further microbial agents;A 10 mg
B n/a
C n/a
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

desipramine
50-47-5

desipramine

B

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

C

10-Hydroxyimipramine
796-28-1

10-Hydroxyimipramine

D

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

Conditions
ConditionsYield
In water for 480h; Ambient temperature; C. blakesleeana (ATCC 8688a); further microbial agents; Further byproducts given;A n/a
B n/a
C 30 mg
D 88 mg
2-((2Ξ,4S)-3,4r-dimethyl-5c-phenyl-oxazolidin-2-yl)-phenol
927207-60-1

2-((2Ξ,4S)-3,4r-dimethyl-5c-phenyl-oxazolidin-2-yl)-phenol

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With buffer solution; potassium chloride In water at 37℃; Rate constant; other reagents;
[3-(10,11-Dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-ethyl-methyl-amine
19009-26-8

[3-(10,11-Dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-ethyl-methyl-amine

A

desipramine
50-47-5

desipramine

B

10,11-dihydro-N-ethyl-5H-dibenzazepine-5-propanamine
2095-96-7

10,11-dihydro-N-ethyl-5H-dibenzazepine-5-propanamine

Conditions
ConditionsYield
With liver microsomes of a rat Product distribution; other reagent (anodic oxidation);
[3-(10,11-Dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-isopropyl-methyl-amine
81256-33-9

[3-(10,11-Dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-isopropyl-methyl-amine

A

desipramine
50-47-5

desipramine

B

10,11-dihydro-N-isopropyl-5H-dibenzazepine-5-propanamine
2292-76-4

10,11-dihydro-N-isopropyl-5H-dibenzazepine-5-propanamine

Conditions
ConditionsYield
With liver microsomes of a rat Product distribution; other reagent (anodic oxidation);
Butyl-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-methyl-amine
81256-34-0

Butyl-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-methyl-amine

A

desipramine
50-47-5

desipramine

B

10,11-dihydro-N-butyl-5H-dibenzazepine-5-propanamine
2064-08-6

10,11-dihydro-N-butyl-5H-dibenzazepine-5-propanamine

Conditions
ConditionsYield
With liver microsomes of a rat Product distribution; other reagent (anodic oxidation);
(4S,5R)-2-tert-Butyl-3,4-dimethyl-5-phenyl-oxazolidine

(4S,5R)-2-tert-Butyl-3,4-dimethyl-5-phenyl-oxazolidine

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With buffer solution; potassium chloride In water at 37℃; Rate constant; other reagents;
(4S,5R)-2-Ethyl-3,4-dimethyl-5-phenyl-oxazolidine

(4S,5R)-2-Ethyl-3,4-dimethyl-5-phenyl-oxazolidine

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With buffer solution; potassium chloride In water at 37℃; Rate constant; other reagents;
Allyl-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-methyl-amine

Allyl-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-methyl-amine

A

desipramine
50-47-5

desipramine

B

acrolein
107-02-8

acrolein

Conditions
ConditionsYield
With oxygen; palladium on activated charcoal In methanol for 24h; Product distribution; Ambient temperature; heterogeneous catalytical dealkylation;
[3-(10,11-Dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-methyl-((E)-3-phenyl-allyl)-amine

[3-(10,11-Dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-methyl-((E)-3-phenyl-allyl)-amine

A

(E)-3-phenylpropenal
14371-10-9

(E)-3-phenylpropenal

B

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With oxygen; palladium on activated charcoal In methanol for 24h; Product distribution; Ambient temperature; heterogeneous catalytical dealkylation;
(4S)-2,2,3,4r-tetramethyl-5c-phenyl-oxazolidine
51018-29-2

(4S)-2,2,3,4r-tetramethyl-5c-phenyl-oxazolidine

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With buffer solution; potassium chloride In water at 37℃; Rate constant; other reagents;
(4S,5R)-3,4-dimethyl-5-phenyl-1,3-oxazolidine
123618-06-4

(4S,5R)-3,4-dimethyl-5-phenyl-1,3-oxazolidine

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With buffer solution; potassium chloride In water at 37℃; Rate constant; other reagents;
(2R)-3c,4-dimethyl-2r-phenyl-1-oxa-4-aza-spiro[4.5]decane
102339-76-4

(2R)-3c,4-dimethyl-2r-phenyl-1-oxa-4-aza-spiro[4.5]decane

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With buffer solution; potassium chloride In water at 37℃; Rate constant; other reagents;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

desipramine
50-47-5

desipramine

B

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

Conditions
ConditionsYield
With NADP; cDNA-expressed human recombinant CYP1A2 In phosphate buffer at 37℃; for 0.25h; pH=7.4; Enzyme kinetics; Further Variations:; concentration;
desipramine hydrochloride
58-28-6

desipramine hydrochloride

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
With sodium hydrogencarbonate In dichloromethane; water
With sodium hydrogencarbonate In methanol at 20℃; for 0.5h;1.79 g
methanol
67-56-1

methanol

C20H23ClN2O2

C20H23ClN2O2

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
for 2h; Reflux;1.43 g
C19H22N2O

C19H22N2O

desipramine
50-47-5

desipramine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: potassium hydroxide / water; methanol / 1.5 h / 160 °C / Microwave irradiation
2.1: montmorillonite K-10 / methanol / 0.25 h / 20 °C
2.2: montmorillonite K-10 / 0.67 h / 80 °C / Microwave irradiation
View Scheme
desipramine
50-47-5

desipramine

carbon dioxide
1111-72-4

carbon dioxide

[N-13CH3]-imipramine

[N-13CH3]-imipramine

Conditions
ConditionsYield
With hydrogen; tris(acetylacetonato)ruthenium(III); lithium chloride; [2-((diphenylphospino)methyl)-2-methyl-1,3-propanediyl]bis[diphenylphosphine] In tetrahydrofuran at 140℃; for 20h; Autoclave; Inert atmosphere;95%
desipramine
50-47-5

desipramine

tert-butyl 2-(4-fluorophenyl)diazene-1-carboxylate
1262991-68-3

tert-butyl 2-(4-fluorophenyl)diazene-1-carboxylate

N'-(4-{[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-methyl-amino}phenyl)-diazocarboxylic acid tert-butyl ester
1262991-86-5

N'-(4-{[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-methyl-amino}phenyl)-diazocarboxylic acid tert-butyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;92%
desipramine
50-47-5

desipramine

d(4)-methanol
811-98-3

d(4)-methanol

10,11-dihydro-N-methyl-N-(methyl-d3)-5H-dibenz(b,f)azepine-5-propanamine
65100-48-3

10,11-dihydro-N-methyl-N-(methyl-d3)-5H-dibenz(b,f)azepine-5-propanamine

Conditions
ConditionsYield
With aluminum (III) chloride; water-d2 In acetonitrile for 24h; Inert atmosphere; Irradiation;92%
desipramine
50-47-5

desipramine

deuteromethanol
1455-13-6

deuteromethanol

C19H23(2)HN2

C19H23(2)HN2

Conditions
ConditionsYield
With aluminum (III) chloride; water In acetonitrile for 24h; Inert atmosphere; Irradiation;92%
desipramine
50-47-5

desipramine

acrylonitrile
107-13-1

acrylonitrile

N-cyanoethyldesipramine

N-cyanoethyldesipramine

Conditions
ConditionsYield
In methanol at 20℃;90%
desipramine
50-47-5

desipramine

carbon dioxide
124-38-9

carbon dioxide

impramine
50-49-7

impramine

Conditions
ConditionsYield
With hydrogen In octane at 150℃; for 30h; Autoclave;89%
With hydrogen; tris(acetylacetonato)ruthenium(III); lithium chloride; [2-((diphenylphospino)methyl)-2-methyl-1,3-propanediyl]bis[diphenylphosphine] In tetrahydrofuran at 140℃; for 24h; Autoclave; Inert atmosphere;83 %Chromat.
With proazaphosphatrane; 9-bora-bicyclo[3.3.1]nonane In tetrahydrofuran at 90℃; under 750.075 Torr; for 1h; Inert atmosphere; Schlenk technique; chemoselective reaction;99 %Spectr.
desipramine
50-47-5

desipramine

d(4)-methanol
811-98-3

d(4)-methanol

C19H22(2)H2N2

C19H22(2)H2N2

Conditions
ConditionsYield
With aluminum (III) chloride; water In acetonitrile for 24h; Inert atmosphere; Irradiation;89%
desipramine
50-47-5

desipramine

chloranil
118-75-2

chloranil

3,6-Dichlor-2,5-bis-N-methyl-3-(10,11-dihydro-5H-dibenzoazepin-5-yl)propylamino-1,4-benzochinon
109423-34-9

3,6-Dichlor-2,5-bis-N-methyl-3-(10,11-dihydro-5H-dibenzoazepin-5-yl)propylamino-1,4-benzochinon

Conditions
ConditionsYield
In dichloromethane for 48h;80%
desipramine
50-47-5

desipramine

oct-1-ene
111-66-0

oct-1-ene

desipramine-N-(2-methyl)octylamine

desipramine-N-(2-methyl)octylamine

Conditions
ConditionsYield
With (3-(tert-butyl)-2-oxoimidazolidin-1-ide)Ta(CH2SiMe3)3CI In (2)H8-toluene at 105℃; for 3h; Inert atmosphere;75%
desipramine
50-47-5

desipramine

1-{2-[2-(2-bromo-ethoxy)-ethoxy]-ethoxy}-2-methoxy-ethane
110429-45-3

1-{2-[2-(2-bromo-ethoxy)-ethoxy]-ethoxy}-2-methoxy-ethane

C27H40N2O4

C27H40N2O4

Conditions
ConditionsYield
Stage #1: desipramine With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: 1-{2-[2-(2-bromo-ethoxy)-ethoxy]-ethoxy}-2-methoxy-ethane In N,N-dimethyl-formamide for 16h;
74%
desipramine
50-47-5

desipramine

1-oxyl-2,2,5,5-tetramethylpyrrolidinyl-3-carboxylic acid N-hydroxysuccinimide ester
58537-73-8

1-oxyl-2,2,5,5-tetramethylpyrrolidinyl-3-carboxylic acid N-hydroxysuccinimide ester

C27H36N3O2

C27H36N3O2

Conditions
ConditionsYield
In tetrahydrofuran 1) 4d, RT, 2) 50-60 deg C, 3 d;63%
desipramine
50-47-5

desipramine

p-benzoquinone
106-51-4

p-benzoquinone

A

2-azepin-5-yl)-propyl-amino>-1,4-benzochinon
80596-46-9

2-azepin-5-yl)-propyl-amino>-1,4-benzochinon

B

2,5-Bis-azepin-5-yl)-propylamino>-1,4-benzochinon
80596-47-0

2,5-Bis-azepin-5-yl)-propylamino>-1,4-benzochinon

Conditions
ConditionsYield
With sodium carbonate In dichloromethane for 1h; Ambient temperature;A 60%
B 25%
desipramine
50-47-5

desipramine

2β-(2-iodoethyloxy)-1α,3β,25-tris(triethylsilyloxy)cholesta-5,7-diene

2β-(2-iodoethyloxy)-1α,3β,25-tris(triethylsilyloxy)cholesta-5,7-diene

2β-(2-methoxycarbonylethyloxy)-1α,3β,25-trihydroxycholesta-5,7-diene
246237-62-7

2β-(2-methoxycarbonylethyloxy)-1α,3β,25-trihydroxycholesta-5,7-diene

Conditions
ConditionsYield
In hexane; ethyl acetate59%
desipramine
50-47-5

desipramine

diphenyldisulfane
882-33-7

diphenyldisulfane

N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-N-methyl-S-phenylthiohydroxylamine

N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-N-methyl-S-phenylthiohydroxylamine

Conditions
ConditionsYield
With silver nitrate In methanol at 25℃; for 1h;55%
desipramine
50-47-5

desipramine

2-Methyl-1,4-benzoquinone
553-97-9

2-Methyl-1,4-benzoquinone

A

5-Methyl-2-azepin-5-yl)propylamino>-1,4-benzochinon
108141-73-7

5-Methyl-2-azepin-5-yl)propylamino>-1,4-benzochinon

B

6-Methyl-2-azepin-5-yl)propylamino>-1,4-benzochinon
108141-77-1

6-Methyl-2-azepin-5-yl)propylamino>-1,4-benzochinon

Conditions
ConditionsYield
In dichloromethane for 24h; Ambient temperature;A 53%
B 31%
desipramine
50-47-5

desipramine

tetrabromobenzoquinone
488-48-2

tetrabromobenzoquinone

3,5,6-Tribrom-2-azepin-5-yl)propylamino>-1,4-benzochinon

3,5,6-Tribrom-2-azepin-5-yl)propylamino>-1,4-benzochinon

Conditions
ConditionsYield
In dichloromethane52%
desipramine
50-47-5

desipramine

C14H17N3O2

C14H17N3O2

S-rivastigmine-desipramine
1046487-44-8

S-rivastigmine-desipramine

Conditions
ConditionsYield
With sodium hydrogencarbonate In dichloromethane52%
With sodium carbonate In dichloromethane52%
desipramine
50-47-5

desipramine

chloranil
118-75-2

chloranil

A

3,5,6-Trichlor-2-azepin-5-yl)propylamino>-1,4-benzochinon

3,5,6-Trichlor-2-azepin-5-yl)propylamino>-1,4-benzochinon

B

3,6-Dichlor-2,5-bis-N-methyl-3-(10,11-dihydro-5H-dibenzoazepin-5-yl)propylamino-1,4-benzochinon
109423-34-9

3,6-Dichlor-2,5-bis-N-methyl-3-(10,11-dihydro-5H-dibenzoazepin-5-yl)propylamino-1,4-benzochinon

Conditions
ConditionsYield
In dichloromethane for 0.5h;A 51%
B 8%
2,3-Dichloro-1,4-naphthoquinone
117-80-6

2,3-Dichloro-1,4-naphthoquinone

desipramine
50-47-5

desipramine

3-Chlor-2-azepin-5-yl)-propyl-amino>-1,4-naphthochinon

3-Chlor-2-azepin-5-yl)-propyl-amino>-1,4-naphthochinon

Conditions
ConditionsYield
In dichloromethane for 0.5h;50%
desipramine
50-47-5

desipramine

[1,4]naphthoquinone
130-15-4

[1,4]naphthoquinone

2-azepin-5-yl)-propylamino>-1,4-naphthochinon

2-azepin-5-yl)-propylamino>-1,4-naphthochinon

Conditions
ConditionsYield
In dichloromethane for 1h; Ambient temperature; in the dark;50%
methanol
67-56-1

methanol

desipramine
50-47-5

desipramine

impramine
50-49-7

impramine

Conditions
ConditionsYield
With rhodium(III) chloride hydrate; potassium tert-butylate at 150℃; for 60h; Sealed tube; High pressure;49%
desipramine
50-47-5

desipramine

2-bromo-3-methyl-[1,4]naphthoquinone
3129-39-3

2-bromo-3-methyl-[1,4]naphthoquinone

3-azepin-5-yl)-propylamino>-2-azepin-5-yl)-propylaminomethyl>-1,4-naphthochinon

3-azepin-5-yl)-propylamino>-2-azepin-5-yl)-propylaminomethyl>-1,4-naphthochinon

Conditions
ConditionsYield
In ethanol for 24h; Ambient temperature;48%
desipramine
50-47-5

desipramine

2,3-Dibromo-1,4-naphthoquinone
13243-65-7

2,3-Dibromo-1,4-naphthoquinone

3-Brom-2-azepin-5-yl)-propylamino>-1,4-naphthochinon

3-Brom-2-azepin-5-yl)-propylamino>-1,4-naphthochinon

Conditions
ConditionsYield
In dichloromethane for 1h;42%
desipramine
50-47-5

desipramine

2-azepin-5-yl)-propyl-amino>-1,4-benzochinon
80596-46-9

2-azepin-5-yl)-propyl-amino>-1,4-benzochinon

2,5-Bis-azepin-5-yl)-propylamino>-1,4-benzochinon
80596-47-0

2,5-Bis-azepin-5-yl)-propylamino>-1,4-benzochinon

Conditions
ConditionsYield
In chloroform for 12h; Ambient temperature;40%
desipramine
50-47-5

desipramine

1-(2-Chloroethyl)-4-methoxybenzene
18217-00-0

1-(2-Chloroethyl)-4-methoxybenzene

3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-[2-(4-methoxyphenyl)ethyl]-N-methylpropan-1-amine
1026480-32-9

3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-[2-(4-methoxyphenyl)ethyl]-N-methylpropan-1-amine

Conditions
ConditionsYield
Stage #1: desipramine With n-butyllithium In tetrahydrofuran; hexane; toluene at -78℃; for 1h; Inert atmosphere;
Stage #2: 1-(2-Chloroethyl)-4-methoxybenzene With triisobutylaluminum In tetrahydrofuran; hexane; toluene Reflux; Inert atmosphere;
39%

Desipramine Chemical Properties

IUPAC Name: 3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine
The MF of Desipramine (CAS NO.50-47-5) is C18H22N2.

                      
The MW of Desipramine (CAS NO.50-47-5) is 266.38.
Synonyms of Desipramine (CAS NO.50-47-5): (3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine ; 10,11-Dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine ; 5-(g-Methylaminopropyl)iminodibenzyl ; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-
Index of Refraction: 1.576 
EINECS: 200-040-0
Density: 1.047 g/ml 
Flash Point: 160.5 °C
Boiling Point: 407.4 °C
Form: powder
Color: white

Desipramine Uses

  Desipramine (CAS NO.50-47-5) is used in chemical reagents, organic intermediates, fine chemicals, pharmaceutical research and development.

Desipramine Toxicity Data With Reference

1.    

dnd-esc 20 µmol/L

    MUREAV    Mutation Research. 89 (1981),95.
2.    

cyt-oin-unr 10 g/L

    JCLBA3    Journal of Cell Biology. 47 (1970),182a.
3.    

orl-wmn LDLo:30 mg/kg:BRN,CNS

    34ZIAG    Toxicology of Drugs and Chemicals ,Deichmann, W.B.,New York, NY.: Academic Press, Inc.,1969,201.
4.    

orl-chd LDLo:125 mg/kg:CNS,PUL

    PSYPAG    Psychopharmacologia (Berlin). 10 (1967),431.
5.    

orl-hmn LDLo:30 mg/kg:CNS,BRN,PUL

    DMWOAX    Deutsche Medizinische Wochenschrift. 93 (1968),117.
6.    

orl-rat LD50:375 mg/kg

    ARZNAD    Arzneimittel-Forschung. Drug Research. 19 (1969),1617.
7.    

ipr-rat LD50:48 mg/kg

    ARZNAD    Arzneimittel-Forschung. Drug Research. 20 (1970),1561.
8.    

scu-rat LD50:183 mg/kg

    ARZNAD    Arzneimittel-Forschung. Drug Research. 20 (1970),1561.
9.    

ivn-rat LD50:29 mg/kg

    AIPTAK    Archives Internationales de Pharmacodynamie et de Therapie. 148 (1964),560.
10.    

orl-mus LD50:448 mg/kg

    JJPAAZ    Japanese Journal of Pharmacology. 21 (1971),47.

Desipramine Safety Profile

Human poison by ingestion. Experimental poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Human systemic effects by ingestion: degenerative brain changes, tremors, coma, and cyanosis. An experimental teratogen. Other experimental reproductive effects. Mutation data reported. An antidepressant. Related to diazepam. When heated to decomposition it emits toxic fumes of NOx.Safety information of Desipramine (CAS NO.50-47-5):
Hazard Codes  HarmfulXn
Risk Statements 
20/21/22 Harmful by inhalation, in contact with skin and if swallowed
Safety Statements 
36 Wear suitable protective clothing
WGK Germany  3

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View